Gene_name	variation	Clinical significance	Review status	uniprot	two_states	length	GO_number	Int_number	Occurrence_in_proteins{%)_n	Volume_(A3)_n	kdHydrophobicity_n	Propensity_alpha_n	Occurrence_in_proteins{%)_m	Volume_(A3)_m	kdHydrophobicity_m	Propensity_alpha_m	Occurrence_in_proteins{%)_DELTAmn	Volume_(A3)_DELTAmn	kdHydrophobicity_DELTAmn	Propensity_alpha_DELTAmn	plddt_mean	plddt_median	plddt	ASA	SS_cat	b62	WT_PSIC	MUT_PSIC	DELTA_PSIC	SIFT_score	SIFT_converted_rankscore	SIFT_pred	Polyphen2_HDIV_score	Polyphen2_HDIV_rankscore	Polyphen2_HDIV_pred	Polyphen2_HVAR_score	Polyphen2_HVAR_rankscore	Polyphen2_HVAR_pred	LRT_score	LRT_converted_rankscore	LRT_pred	MutationTaster_score	MutationTaster_converted_rankscore	MutationTaster_pred	MutationAssessor_score	MutationAssessor_score_rankscore	MutationAssessor_pred	FATHMM_score	FATHMM_converted_rankscore	FATHMM_pred	PROVEAN_score	PROVEAN_converted_rankscore	PROVEAN_pred	VEST3_score	VEST3_rankscore	MetaSVM_score	MetaSVM_rankscore	MetaSVM_pred	MetaLR_score	MetaLR_rankscore	MetaLR_pred	M-CAP_score	M-CAP_rankscore	M-CAP_pred	CADD_raw	CADD_raw_rankscore	CADD_phred	DANN_score	DANN_rankscore	fathmm-MKL_coding_score	fathmm-MKL_coding_rankscore	fathmm-MKL_coding_pred	GenoCanyon_score	GenoCanyon_score_rankscore	integrated_fitCons_score	integrated_fitCons_score_rankscore	integrated_confidence_value	GERP++_RS	GERP++_RS_rankscore	phyloP100way_vertebrate	phyloP100way_vertebrate_rankscore	phyloP20way_mammalian	phyloP20way_mammalian_rankscore	phastCons100way_vertebrate	phastCons100way_vertebrate_rankscore	phastCons20way_mammalian	phastCons20way_mammalian_rankscore	SiPhy_29way_logOdds	SiPhy_29way_logOdds_rankscore	HCPrf	HCPrf_prob
APC	S1028I	Likely pathogenic	reviewed by expert panel	P25054	1	2843	55	0	7.4	99	-0.8	0.79	5.5	169	3.8	1	-1.9	70	4.6	0.21	59.61337143	42.46	36	0.323076923	0	-2	-1.348	-3.521	-2.173	0	0.912	1	0.999	0.764	1	0.998	0.875	1	0	0.843	1	1	0.81	1	0.695	0.181	0	-6.56	0.997	1	-3.7	0.705	1	0.86	0.963	1.113	0.999	1	0.972	0.991	1	0.371	0.928	1	5.721	0.781	26.9	0.995	0.705	0.993	0.943	1	1	0.747	0.707	0.73	0	5.76	0.907	9.356	0.965	1.048	0.713	1	0.715	0.999	0.75	19.57	0.954	0	0.264649243
ATM	R189K	Benign	criteria provided, multiple submitters, no conflicts	Q13315	0	3056	87	0	5.2	225	-4.5	0.79	5.8	171	-3.9	1.07	0.6	-54	0.6	0.28	80.44527143	87.455	93.02	0.326612903	2	2	-1.101	-2.638	-1.537	0	0.912	1	1	0.899	1	0.994	0.807	1	0	0.843	1	0.997	0.437	1	2.475	0.721	1	4.29	0.389	0	-1.86	0.435	0	0.741	0.738	-0.744	0.583	0	0.264	0.635	0				5.078	0.684	25.3	0.996	0.742	0.973	0.739	1	1	0.747	0.651	0.465	0	5.59	0.846	6.461	0.732	1.048	0.713	1	0.715	1	0.888	19.595	0.955	1	0.612952774
ATM	L546V	Benign/Likely benign	criteria provided, multiple submitters, no conflicts	Q13315	0	3056	87	0	9.1	168	4.5	1.34	6.5	142	4.2	1.14	-2.6	-26	-0.3	-0.2	80.44527143	87.455	89.66	0	2	1	-1.123	-2.774	-1.651	0.007	0.599	1	0.539	0.36	1	0.36	0.414	0	0.047	0.233	0	1	0.09	0	2.535	0.741	1	0.17	0.605	0	-1.57	0.379	0	0.091	0.196	-1.02	0.239	0	0.025	0.109	0				1.485	0.241	13.24	0.973	0.328	0.227	0.216	0	0.705	0.227	0.651	0.465	0	-1.48	0.082	-0.169	0.098	-0.401	0.062	0.002	0.151	0.628	0.294	7.218	0.25	1	0.549335167
ERCC5	M254V	Benign	criteria provided, multiple submitters, no conflicts	P28715	0	1186	24	0	2.8	171	1.9	1.2	6.5	142	4.2	1.14	3.7	-29	2.3	-0.06	57.05793423	51.665	77.68	0.04787234	2	1	-1.559	-2.746	-1.187	0.026	0.469	1	0.994	0.647	1	0.853	0.59	1	0	0.843	1	0.999	0.455	1	2.54	0.743	1	2.15	0.193	0	-3.35	0.664	1	0.286	0.49	-1.135	0.016	0	0.026	0.112	0				4.302	0.576	24	0.989	0.471	0.941	0.598	1	1	0.5	0.732	0.924	0	5.59	0.846	2.918	0.483	1.199	0.96	1	0.715	1	0.888	8.155	0.302	1	0.541976158
BRCA1	R1495T	Pathogenic	reviewed by expert panel	P38398	1	1863	90	0	5.2	225	-4.5	0.79	6	122	-0.7	0.82	0.8	-103	3.8	0.03	41.28535695	30.66	29.59	0.858870968	0	-1	-2.084	-3.288	-1.204	0.003	0.912	1	0.967	0.544	1	0.916	0.634	1	0.122	0.19	0	0.834	0.81	1	1.895	0.505	0	-2.33	0.889	1	-1.09	0.58	0	0.665	0.717	0.56	0.914	1	0.734	0.909	1	0.82	0.986	1	3.7	0.502	23.3	0.977	0.348	0.89	0.489	1	0.043	0.146	0.706	0.609	0	4.97	0.653	3.879	0.556	0.935	0.49	1	0.715	0.639	0.296	13.587	0.612	0	0.1325768
BRCA1	G1748S	Likely benign	criteria provided, single submitter	P38398	0	1863	90	0	7.1	66	-0.4	0.53	7.4	99	-0.8	0.79	0.3	33	-0.4	0.26	41.28535695	30.66	95.47	0	2	0	-2.078	-3.222	-1.144	0	0.912	1	1	0.899	1	0.999	0.971	1	0	0.466	1	1	0.81	1	2.045	0.562	1	-2.06	0.859	1	-1.09	0.807	0	0.904	0.894	1.053	0.982	1	0.934	0.978	1	0.636	0.969	1	5.303	0.717	25.8	0.998	0.91	0.936	0.583	1	0.059	0.152	0.732	0.924	0	5.07	0.68	4.681	0.611	0.93	0.439	1	0.715	0.998	0.697	13.823	0.627	1	0.622810637
BRCA1	E1559K	Pathogenic	reviewed by expert panel	P38398	1	1863	90	0	6.3	155	-3.5	1.53	5.8	171	-3.9	1.07	-0.5	16	-0.4	-0.46	41.28535695	30.66	29.18	0.809278351	0	1	-2.202	-3.388	-1.186	0.003	0.682	1	0.761	0.416	1	0.182	0.405	0	0.001	0.394	0	1	0.81	1	1.75	0.456	0	-2.42	0.908	1	-0.48	0.379	0	0.784	0.775	-0.07	0.808	0	0.596	0.856	1	0.852	0.989	1	5.932	0.814	27.6	0.998	0.923	0.965	0.695	1	0.236	0.185	0.732	0.924	0	5.54	0.828	3.38	0.519	0.928	0.438	0.985	0.357	0.993	0.574	14.857	0.699	0	0.025447043
BRCA1	E1559Q	Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	P38398	1	1863	90	0	6.3	155	-3.5	1.53	4.1	161	-3.5	1.17	-2.2	6	0	-0.36	41.28535695	30.66	29.18	0.809278351	0	2	-2.202	-3.723	-1.521	0.004	0.654	1	0.761	0.428	1	0.301	0.487	0	0.001	0.394	0	1	0.81	1	1.75	0.456	0	-2.46	0.91	1	-0.36	0.34	0	0.747	0.753	-0.019	0.819	0	0.667	0.885	1	0.885	0.991	1	4.791	0.643	24.7	0.998	0.845	0.968	0.71	1	0.236	0.185	0.732	0.924	0	5.54	0.828	3.38	0.519	0.928	0.438	0.985	0.357	0.993	0.574	14.857	0.699	0	0.08083448
BRCA1	D1818G	Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	P38398	1	1863	90	0	5.2	125	-3.5	0.98	7.1	66	-0.4	0.53	1.9	-59	3.1	-0.45	41.28535695	30.66	64.96	0.797546012	0	-1	-2.036	-3.198	-1.162	0.002	0.721	1	0.753	0.414	1	0.237	0.368	0	0	0.523	1	0.276	0.81	1				-2.55	0.896	1	-1.25	0.669	0	0.651	0.723	-0.029	0.817	0	0.471	0.797	0	0.686	0.974	1	2.834	0.401	21.5	0.968	0.308	0.635	0.318	1	0.003	0.1	0.707	0.73	0	3.9	0.441	1.776	0.38	0.961	0.567	0.947	0.327	0.842	0.351	7.514	0.266	0	0.172283356
BRCA1	V1736A	Pathogenic	reviewed by expert panel	P38398	1	1863	90	0	6.5	142	4.2	1.14	7.5	92	1.8	1.45	1	-50	-2.4	0.31	41.28535695	30.66	97.64	0	0	0	-1.949	-2.985	-1.036	0	0.912	1	0.998	0.899	1	0.993	0.916	1	0.001	0.41	1	0.997	0.81	1	3.265	0.902	1	-2.24	0.872	1	-0.73	0.666	0	0.927	0.919	0.852	0.951	1	0.842	0.947	1	0.754	0.981	1	4.673	0.626	24.5	0.999	0.956	0.957	0.656	1	0.011	0.121	0.732	0.924	0	5.07	0.68	5.554	0.668	1.192	0.91	1	0.715	1	0.888	11.15	0.475	0	0.484525447
BRCA1	M1361L	Benign	reviewed by expert panel	P38398	0	1863	90	0	2.8	171	1.9	1.2	9.1	168	4.5	1.34	6.3	-3	2.6	0.14	41.28535695	30.66	32.43	0.909574468	0	2	-2.83	-3.039	-0.209	0.043	0.546	1	0.001	0.09	0	0.001	0.063	0	0.133	0.186	0	1	0.09	0	0.69	0.17	0	-2.14	0.877	1	-0.12	0.092	0	0.539	0.58	-0.619	0.641	0	0.41	0.759	0	0.066	0.699	1	1.553	0.248	13.6	0.789	0.121	0.088	0.145	0	0.692	0.226	0.732	0.924	0	1.34	0.209	-0.725	0.05	-1.009	0.022	0	0.063	0.077	0.179	7.179	0.248	1	0.514236589
BRCA1	R1699Q	Pathogenic	reviewed by expert panel	P38398	1	1863	90	0	5.2	225	-4.5	0.79	4.1	161	-3.5	1.17	-1.1	-64	1	0.38	41.28535695	30.66	96	0.286290323	0	1	-2.39	-3.963	-1.573	0	0.912	1	1	0.899	1	0.999	0.971	1	0	0.466	1	0.999	0.81	1	3.23	0.897	1	-2.83	0.913	1	-0.56	0.632	0	0.906	0.896	0.936	0.962	1	0.873	0.958	1	0.747	0.98	1	7.757	0.955	35	1	1	0.94	0.594	1	0.502	0.209	0.706	0.609	0	5.83	0.93	4.855	0.624	0.876	0.383	1	0.715	1	0.888	15.622	0.765	0	0.398395232
BRCA1	L1664P	Benign	reviewed by expert panel	P38398	0	1863	90	0	9.1	168	4.5	1.34	5.1	129	-1.6	0.59	-4	-39	-6.1	-0.75	41.28535695	30.66	95.27	0.426829268	2	-3	-2.162	-2.618	-0.456	0.037	0.481	1	0.029	0.235	0	0.074	0.279	0	0.178	0.172	0	0.998	0.447	1	2.615	0.767	1	-2.18	0.867	1	-0.95	0.778	0	0.612	0.721	-0.324	0.743	0	0.524	0.823	1	0.604	0.965	1	2.325	0.341	18.33	0.934	0.225	0.665	0.328	1	0.002	0.095	0.732	0.924	0	1.62	0.227	2.289	0.429	-0.304	0.08	0.928	0.32	0.154	0.206	4.902	0.13	1	0.657290234
BRCA1	P1812A	Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	P38398	1	1863	90	0	5.1	129	-1.6	0.59	7.5	92	1.8	1.45	2.4	-37	3.4	0.86	41.28535695	30.66	91.28	0.301470588	2	-1	-2.183	-2.246	-0.063	0	0.912	1	1	0.899	1	0.996	0.875	1	0	0.497	1	0.961	0.382	1				-1.46	0.899	0	-1.46	0.879	0	0.673	0.721	0.541	0.911	1	0.63	0.87	1	0.689	0.974	1	5.217	0.705	25.6	0.995	0.692	0.906	0.516	1	0.546	0.213	0.707	0.73	0	4.98	0.655	3.679	0.541	0.949	0.536	1	0.715	0.984	0.507	13.62	0.614	0	0.389614856
BRCA1	G1706A	Benign	reviewed by expert panel	P38398	0	1863	90	0	7.1	66	-0.4	0.53	7.5	92	1.8	1.45	0.4	26	2.2	0.92	41.28535695	30.66	95.97	0	2	0	-1.663	-2.978	-1.315	0	0.912	1	1	0.899	1	1	0.971	1	0	0.504	1	1	0.81	1	1.88	0.501	0	-0.49	0.704	0	-0.84	0.799	0	0.833	0.893	-0.084	0.805	0	0.469	0.796	0	0.377	0.929	1	5.954	0.818	27.7	0.998	0.914	0.953	0.641	1	0.502	0.209	0.706	0.609	0	5.83	0.93	4.855	0.624	0.876	0.383	1	0.715	0.997	0.653	15.622	0.765	1	0.609520534
BRCA2	G173R	Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	P51587	1	3418	46	0	7.1	66	-0.4	0.53	5.2	225	-4.5	0.79	-1.9	159	-4.1	0.26	38.62943571	34.55	37.47	0.833333333	0	-2	-1.161	-3.536	-2.375	0.002	0.721	1	0.994	0.899	1	0.953	0.79	1	0.064	0.22	0	0.51	0.316	0	2.19	0.618	1	5.85	0.007	0	-1.55	0.375	0	0.607	0.699	-0.97	0.371	0	0.008	0.027	0	0.031	0.533	1	4.99	0.671	25.1	0.999	0.988	0.895	0.497	1	0.996	0.347	0.651	0.465	0	4.64	0.572	2.038	0.406	0.061	0.167	1	0.715	0.69	0.307	8.91	0.345	0	0.282737276
BRCA2	V211L	Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	P51587	1	3418	46	0	6.5	142	4.2	1.14	9.1	168	4.5	1.34	2.6	26	0.3	0.2	38.62943571	34.55	31.81	0.936619718	0	1	-1.782	-2.286	-0.504	0.029	0.457	1	0.734	0.408	1	0.196	0.35	0	0.908	0.086	0	0.917	0.273	0	1.83	0.482	0	5.66	0.008	0	-0.64	0.187	0	0.699	0.703	-0.858	0.514	0	0.005	0.015	0				5.188	0.7	25.5	0.998	0.867	0.966	0.699	1	1	0.48	0.651	0.465	0	5.65	0.868	3.913	0.559	0.949	0.536	1	0.715	0.999	0.75	12.985	0.578	0	0.151467217
BRIP1	H478R	Benign/Likely benign	criteria provided, multiple submitters, no conflicts	Q9BX63	0	1249	32	0	2.2	167	-3.2	1.24	5.2	225	-4.5	0.79	3	58	-1.3	-0.45	64.54240993	80.57	92.55	0.690217391	2	0	-1.59	-3.547	-1.957	0.186	0.214	0	0.966	0.542	1	0.543	0.471	1	0.018	0.276	0	0.968	0.258	0	2.045	0.562	1	-0.77	0.741	0	-2.45	0.535	0	0.299	0.359	-0.583	0.655	0	0.335	0.702	0				1.059	0.196	10.99	0.967	0.301	0.938	0.59	1	0.049	0.148	0.651	0.465	0	5.24	0.728	5.393	0.658	1.011	0.635	0.997	0.399	0.994	0.587	13.961	0.635	1	0.565107749
CDH1	G274S	Benign	reviewed by expert panel	P12830	0	882	50	0	7.1	66	-0.4	0.53	7.4	99	-0.8	0.79	0.3	33	-0.4	0.26	79.9194898	89.695	90.59	0.69047619	0	0	-1.115	-3.137	-2.022	0.035	0.437	1	0.538	0.899	1	0.423	0.736	0	0.004	0.348	0	0.684	0.332	1	0.055	0.082	0	0.71	0.512	0	-4.31	0.765	1	0.482	0.694	-0.956	0.399	0	0.15	0.477	0	0.013	0.318	0	4.728	0.634	24.6	0.998	0.917	0.862	0.451	1	0.52	0.211	0.707	0.73	0	3.27	0.364	3.032	0.492	1.048	0.713	0.999	0.424	0.931	0.405	11.003	0.466	1	0.569525775
CDH1	D498A	Likely benign	reviewed by expert panel	P12830	0	882	50	0	5.2	125	-3.5	0.98	7.5	92	1.8	1.45	2.3	-33	5.3	0.47	79.9194898	89.695	91.71	0.687116564	0	-2	-1.289	-3.119	-1.83	0.006	0.632	1	0.993	0.637	1	0.973	0.713	1	0	0.513	1	1	0.81	1	2.095	0.583	1	0.67	0.522	0	-4.58	0.811	1	0.909	0.909	-0.55	0.668	0	0.281	0.654	0	0.035	0.562	1	4.538	0.608	24.3	0.995	0.69	0.992	0.928	1	1	0.747	0.707	0.73	0	5.32	0.753	7.104	0.765	1.083	0.853	1	0.715	0.236	0.225	14.944	0.705	1	0.55307526
CDKN2A	D153Y	Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	P42771	1	156	24	0	5.2	125	-3.5	0.98	3.3	203	-1.3	0.61	-1.9	78	2.2	-0.37	74.85929487	81.46	61.74	0.840490798	0	-3	-2.032	-4.08	-2.048	0.045	0.408	1	0.585	0.37	1	0.113	0.301	0				1	0.81	1	1.545	0.392	0	-1.23	0.822	0	-1.08	0.281	0			-0.809	0.546	0	0.193	0.546	0				10.488	0.968	36	0.989	0.476	0.907	0.519	1	1	0.747	0.61	0.352	0	3.31	0.369	4.068	0.57	0.789	0.32	1	0.715	0.174	0.211	9.714	0.392	0	0.351719395
CDKN2A	A60E	Likely pathogenic	criteria provided, single submitter	P42771	1	156	24	0	7.5	92	1.8	1.45	6.3	155	-3.5	1.53	-1.2	63	-5.3	0.08	74.85929487	81.46	84.19	0	2	-1	-1.355	-2.972	-1.617	0.001	0.784	1	0.997	0.689	1	0.833	0.58	1				1	0.81	1				-1.38	0.803	0	-4.62	0.791	1	0.933	0.938	0.333	0.881	1	0.636	0.872	1	0.822	0.986	1	5.987	0.823	27.8	0.995	0.708	0.978	0.773	1	1	0.983	0.677	0.55	0	5.79	0.917	6.193	0.718	1.048	0.713	1	0.715	0.024	0.14	18.802	0.92	0	0.497845025
ERCC2	E546K	Likely pathogenic	criteria provided, single submitter	P18074	1	760	46	0	6.3	155	-3.5	1.53	5.8	171	-3.9	1.07	-0.5	16	-0.4	-0.46	87.51836842	90.395	91.03	0.603092784	2	1	-1.434	-2.919	-1.485	0.017	0.518	1	0.972	0.554	1	0.877	0.604	1	0	0.843	1	1	0.81	1	2.2	0.622	1	-3.02	0.923	1	-3.48	0.679	1	0.891	0.881	0.933	0.961	1	0.87	0.957	1	0.311	0.912	1	7.283	0.948	34	0.999	0.995	0.945	0.613	1	1	0.747	0.707	0.73	0	5.35	0.762	7.418	0.792	0.935	0.49	1	0.715	1	0.888	16.553	0.843	0	0.404467151
ERCC4	E239K	Likely pathogenic	criteria provided, single submitter	Q92889	1	916	29	0	6.3	155	-3.5	1.53	5.8	171	-3.9	1.07	-0.5	16	-0.4	-0.46	74.50494541	85.2	85.34	0.37628866	2	1	-1.28	-3.102	-1.822	0.003	0.682	1	1	0.899	1	0.999	0.916	1	0	0.843	1	1	0.81	1	3.895	0.962	1	-0.19	0.659	0	-3.69	0.704	1	0.948	0.944	0.265	0.87	1	0.553	0.837	1	0.103	0.778	1	5.72	0.781	26.9	0.999	0.994	0.99	0.898	1	1	0.747	0.732	0.924	0	5.71	0.89	9.602	0.976	1.048	0.713	1	0.715	0.98	0.49	18.856	0.922	0	0.476370603
NF1	R873G	Pathogenic	criteria provided, multiple submitters, no conflicts	P21359	1	2839	109	0	5.2	225	-4.5	0.79	7.1	66	-0.4	0.53	1.9	-159	4.1	-0.26	79.61452857	88.88	31.98	0.733870968	0	-2	-2.285	-1.892	0.393	0.019	0.512	1	0.874	0.629	1	0.283	0.703	0	0	0.843	1	1	0.588	1	2.135	0.597	1	3.11	0.098	0	-3.4	0.67	1	0.914	0.905	-1.163	0.007	0	0.082	0.323	0	0.777	0.983	1	5.48	0.744	26.2	0.999	0.932	0.981	0.792	1	0.976	0.296	0.737	0.974	0	5.44	0.793	5.735	0.68	0.935	0.49	1	0.715	1	0.888	19.241	0.938	0	0.396263182
FANCA	Y359C	Likely benign	criteria provided, single submitter	O15360	0	1455	17	0	3.3	203	-1.3	0.61	1.8	106	2.5	0.77	-1.5	-97	3.8	0.16	74.0636701	80	87.06	0	2	-2	-1.405	-4.905	-3.5	0.003	0.682	1	0.998	0.715	1	0.87	0.6	1	0.161	0.176	0	0.726	0.337	1	2.425	0.705	1	-0.02	0.629	0	-5.73	0.876	1	0.454	0.625	-0.449	0.705	0	0.327	0.695	0	0.094	0.762	1	3.134	0.436	22.6	0.992	0.565	0.891	0.49	1	0.002	0.091	0.722	0.854	0	-1.67	0.078	0.588	0.235	0.126	0.213	0.996	0.391	0.843	0.352	11.839	0.514	1	0.699823148
FANCA	L178F	Likely pathogenic	criteria provided, single submitter	O15360	1	1455	17	0	9.1	168	4.5	1.34	3.9	203	2.8	1.12	-5.2	35	-1.7	-0.22	74.0636701	80	81.21	0.085365854	0	0	-1.632	-3.81	-2.178	0.006	0.912	1	1	0.899	1	0.976	0.875	1	0.001	0.405	0	0.998	0.449	1	2.25	0.64	1	0.84	0.475	0	-2.29	0.705	0	0.498	0.708	-0.641	0.631	0	0.247	0.616	0	0.063	0.689	1	4.007	0.539	23.6	0.998	0.894	0.746	0.362	1	1	0.446	0.707	0.73	0	2.84	0.321	1.707	0.373	1.027	0.646	1	0.715	0.545	0.279	8.45	0.318	0	0.323298618
MSH6	C496Y	Likely benign	reviewed by expert panel	P52701	0	1360	29	0	1.8	106	2.5	0.77	3.3	203	-1.3	0.61	1.5	97	-3.8	-0.16	77.06675735	88.285	92.85	0.037037037	2	-2	-1.666	-3.071	-1.405	0.044	0.446	1	0.865	0.456	1	0.519	0.511	1	0	0.843	1	1	0.81	1	2.085	0.579	1	-1.88	0.873	1	-7.18	0.942	1	0.936	0.93	0.087	0.839	1	0.621	0.867	1	0.091	0.757	1	4.955	0.666	25	0.993	0.586	0.969	0.716	1	1	0.747	0.672	0.522	0	4.45	0.532	5.728	0.68	1.048	0.713	1	0.715	0.986	0.517	15.253	0.731	1	0.782560424
FH	E224K	Likely benign	criteria provided, single submitter	P07954	0	510	21	0	6.3	155	-3.5	1.53	5.8	171	-3.9	1.07	-0.5	16	-0.4	-0.46	92.75319608	98.63	98.77	0.572164948	2	1	-1.646	-2.565	-0.919	0.037	0.43	1	0.027	0.182	0	0.051	0.24	0	0	0.629	1	1	0.81	1	2.76	0.809	1	-6.43	0.997	1	-3.38	0.667	1	0.478	0.527	1.03	0.977	1	0.974	0.992	1	0.516	0.954	1	5.264	0.712	25.7	0.998	0.919	0.984	0.819	1	1	0.747	0.722	0.854	0	5.65	0.868	5.711	0.678	0.935	0.49	1	0.715	0.991	0.552	17.578	0.878	1	0.666348988
GALNT12	R120P	Benign	criteria provided, multiple submitters, no conflicts	Q8IXK2	0	581	7	0	5.2	225	-4.5	0.79	5.1	129	-1.6	0.59	-0.1	-96	2.9	-0.2	93.3110327	98.38	98.27	0.290322581	0	-2	-1.511	-3.61	-2.099	0.512	0.074	0	0.999	0.764	1	0.914	0.632	1	0.005	0.331	0	0.993	0.417	1	0.755	0.192	0	0.29	0.589	0	-0.51	0.16	0	0.684	0.691	-0.831	0.533	0	0.195	0.55	0	0.091	0.758	1	5.377	0.728	25.9	0.995	0.674	0.928	0.564	1	1	0.747	0.767	0.994	0	3.74	0.419	3.165	0.502	0.937	0.529	1	0.715	0.996	0.625	11.209	0.478	1	0.502865658
MSH2	I774V	Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	P43246	1	934	43	0	5.5	169	3.8	1	6.5	142	4.2	1.14	1	-27	0.4	0.14	84.12568522	88.03	95.17	0.130177515	0	3	-1.311	-2.122	-0.811	0.047	0.437	1	0.612	0.438	1	0.3	0.461	0	0	0.629	1	0.999	0.484	1	1.42	0.358	0	-1.95	0.85	1	-0.81	0.242	0	0.662	0.674	-0.082	0.805	0	0.466	0.794	0	0.052	0.648	1	3.306	0.456	22.9	0.999	0.95	0.94	0.596	1	0.2	0.181	0.707	0.73	0	3.92	0.444	5.623	0.672	1.016	0.643	1	0.715	0.999	0.75	10.153	0.418	0	0.212654746
MSH2	Y165D	Likely pathogenic	reviewed by expert panel	P43246	1	934	43	0	3.3	203	-1.3	0.61	5.2	125	-3.5	0.98	1.9	-78	-2.2	0.37	84.12568522	88.03	93.6	0.063063063	1	-3	-1.856	-2.869	-1.013	0.013	0.564	1	0.009	0.176	0	0.019	0.206	0	0	0.843	1	1	0.81	1	2.545	0.745	1	-2.41	0.885	1	-7.31	0.95	1	0.88	0.964	0.32	0.879	1	0.712	0.901	1	0.13	0.813	1	4.448	0.595	24.2	0.986	0.434	0.989	0.889	1	1	0.747	0.719	0.83	0	5.73	0.897	7.956	0.873	1.038	0.658	1	0.715	0.994	0.587	16.031	0.803	0	0.469715727
MSH2	K907N	Likely benign	criteria provided, single submitter	P43246	0	934	43	0	5.8	171	-3.9	1.07	4.6	135	-3.5	0.73	-1.2	-36	0.4	-0.34	84.12568522	88.03	84.18	0.390243902	2	0	-1.628	-3.608	-1.98	0.017	0.555	1	0.947	0.515	1	0.567	0.481	1	0	0.629	1	0.982	0.81	1	1.955	0.53	1	-3	0.922	1	-2.66	0.569	1	0.17	0.56	0.301	0.876	1	0.7	0.897	1	0.107	0.783	1	3.801	0.514	23.4	0.998	0.841	0.916	0.537	1	0.314	0.193	0.732	0.924	0	2.16	0.265	2.203	0.421	0.998	0.613	1	0.715	0.939	0.413	11.028	0.468	1	0.595231545
RET	S32L	Likely pathogenic	criteria provided, single submitter	P07949	1	1114	53	0	7.4	99	-0.8	0.79	9.1	168	4.5	1.34	1.7	69	5.3	0.55	78.95345601	90.29	94.98	0	0	-2	-1.811	-2.265	-0.454	0.313	0.145	0	0.245	0.387	0	0.011	0.193	0	0.002	0.374	0	0.881	0.357	1	2.175	0.612	1	-1.2	0.798	0	-1.5	0.366	0	0.786	0.777	-0.357	0.734	0	0.306	0.677	0	0.033	0.549	1	4.084	0.548	23.7	0.996	0.741	0.838	0.426	1	1	0.443	0.615	0.372	0	5.51	0.817	4.669	0.61	0.935	0.49	0.997	0.399	0.988	0.529	12.401	0.546	0	0.448143054
VHL	F91V	Likely benign	criteria provided, single submitter	P40337	0	213	34	0	3.9	203	2.8	1.12	6.5	142	4.2	1.14	2.6	-61	1.4	0.02	84.53075117	97.41	97.58	0.38071066	0	-1	-1.366	-3.144	-1.778	0.162	0.235	0	0.99	0.899	1	0.878	0.916	1	0	0.843	1	0.847	0.43	1	2.25	0.64	1	-6.92	0.998	1	-5.11	0.831	1	0.854	0.841	0.997	0.971	1	0.99	0.997	1	0.998	1	1	6.578	0.905	31	0.986	0.431	0.972	0.73	1	1	0.983	0.442	0.072	0	5.06	0.677	4.903	0.627	0.884	0.388	1	0.715	1	0.888	12.845	0.57	1	0.841792756
RB1	S149L	Likely benign	criteria provided, multiple submitters, no conflicts	P06400	0	928	80	0	7.4	99	-0.8	0.79	9.1	168	4.5	1.34	1.7	69	5.3	0.55	76.25233836	90.805	86.91	0.107692308	2	-2	-1.638	-2.933	-1.295	0.027	0.465	1	0.752	0.414	1	0.342	0.407	0	0.004	0.345	0	1	0.548	1	2.045	0.562	1	-0.84	0.743	0	-2.21	0.496	0	0.618	0.639	-0.354	0.734	0	0.322	0.692	0	0.056	0.666	1	5.127	0.691	25.4	0.998	0.923	0.872	0.464	1	0.998	0.362	0.732	0.924	0	4.89	0.632	4.946	0.63	0.807	0.329	1	0.715	0.998	0.697	13.535	0.609	1	0.502292526
RB1	D210Y	Benign/Likely benign	criteria provided, multiple submitters, no conflicts	P06400	0	928	80	0	5.2	125	-3.5	0.98	3.3	203	-1.3	0.61	-1.9	78	2.2	-0.37	76.25233836	90.805	81.76	0.208588957	0	-3	-1.147	-4.198	-3.051	0.001	0.784	1	1	0.899	1	0.998	0.875	1	0	0.843	1	1	0.81	1	2.42	0.702	1	-0.93	0.752	0	-5.38	0.849	1	0.352	0.861	0.158	0.852	1	0.564	0.842	1	0.08	0.734	1	6.347	0.877	29.4	0.916	0.203	0.946	0.615	1	1	0.48	0.706	0.609	0	5.59	0.846	7.178	0.77	1.04	0.66	1	0.715	1	0.888	18.357	0.903	1	0.764672169
RB1	E737D	Pathogenic	criteria provided, single submitter	P06400	1	928	80	0	6.3	155	-3.5	1.53	5.2	125	-3.5	0.98	-1.1	-30	0	-0.55	76.25233836	90.805	87.81	0.402061856	2	2	-1.592	-2.303	-0.711	0.041	0.419	1	0.024	0.178	0	0.041	0.226	0	0	0.629	1	1	0.81	1	1.1	0.281	0	-3.12	0.928	1	-1.26	0.318	0	0.323	0.384	0.11	0.844	1	0.714	0.902	1				4.784	0.642	24.7	0.996	0.718	0.972	0.728	1	0.924	0.267	0.706	0.609	0	6.17	0.997	6.274	0.724	1.048	0.713	1	0.715	1	0.888	20.879	0.999	0	0.248555708
MET	S572N	Benign/Likely benign	criteria provided, multiple submitters, no conflicts	P08581	0	1390	38	0	7.4	99	-0.8	0.79	4.6	135	-3.5	0.73	-2.8	36	-2.7	-0.06	79.53625899	88.35	93.5	0.153846154	1	1	-1.363	-3.122	-1.759	0.007	0.721	1	0.999	0.764	1	0.996	0.832	1	0	0.843	1	1	0.489	1	2.57	0.754	1	-1.17	0.782	0	-2	0.461	0	0.283	0.433	0.149	0.85	1	0.548	0.834	1				3.427	0.47	23	0.994	0.624	0.928	0.564	1	0.98	0.3	0.732	0.924	0	5.93	0.959	4.044	0.568	1.048	0.713	0.998	0.411	0.984	0.507	15.791	0.78	1	0.531866116
MET	F841V	Pathogenic	criteria provided, single submitter	P08581	1	1390	38	0	3.9	203	2.8	1.12	6.5	142	4.2	1.14	2.6	-61	1.4	0.02	79.53625899	88.35	86.44	0.137055838	1	-1	-1.527	-1.983	-0.456	0.087	0.379	0	0.999	0.764	1	0.991	0.782	1	0	0.843	1	1	0.588	1	0.805	0.203	0	-0.94	0.762	0	-0.87	0.755	0	0.918	0.911	0.195	0.858	1	0.622	0.867	1	0.101	0.775	1	3.742	0.507	23.3	0.98	0.367	0.966	0.697	1	1	0.462	0.722	0.854	0	5.76	0.907	5.831	0.688	0.913	0.425	1	0.715	1	0.888	16.077	0.807	0	0.231292985
MLH1	Q701H	Pathogenic	reviewed by expert panel	P40692	1	756	34	0	4.1	161	-3.5	1.17	2.2	167	-3.2	1.24	-1.9	6	0.3	0.07	77.38665344	89.36	36.5	0.954545455	0	0	-2.109	-4.648	-2.539	0.11	0.912	0	0.902	0.511	1	0.547	0.48	1	0.184	0.17	0	1	0.52	1	1.915	0.514	0	-2.48	0.961	1	-1	0.303	0	0.873	0.902	0.813	0.946	1	0.848	0.949	1				2.847	0.403	21.6	0.996	0.763	0.987	0.856	1	1	0.747	0.707	0.73	0	4.94	0.645	8.049	0.891	1.048	0.713	1	0.715	0.992	0.562	17.3	0.87	0	0.39482544
MLH1	M1T	Likely benign	criteria provided, single submitter	P40692	0	756	34	0	2.8	171	1.9	1.2	6	122	-0.7	0.82	3.2	-49	-2.6	-0.38	77.38665344	89.36	43.1	1	0	-1	-1.71	-3.157	-1.447	0	0.912	1	0	0.026	0	0	0.013	0				1	0.81	1				-2.76	0.913	1	-1.69	0.406	0			-0.267	0.759	0	0.575	0.847	1	0.125	0.807	1	-0.098	0.085	1.741	0.804	0.127	0.663	0.328	1	0.982	0.303	0.732	0.924	0	-0.669	0.108	-0.31	0.081	0.146	0.234	0.509	0.268	1	0.888	10.745	0.452	1	0.932072444
MLH1	P603R	Likely benign	reviewed by expert panel	P40692	0	756	34	0	5.1	129	-1.6	0.59	5.2	225	-4.5	0.79	0.1	96	-2.9	0.2	77.38665344	89.36	89.19	0.683823529	0	-2	-1.71	-3.96	-2.25	0.013	0.632	1	0.994	0.764	1	0.899	0.66	1	0	0.843	1	1	0.81	1	3.005	0.862	1	-3.26	0.936	1	-4.38	0.846	1	0.859	0.901	0.961	0.966	1	0.899	0.967	1	0.412	0.936	1	6.635	0.91	32	0.998	0.918	0.97	0.722	1	1	0.747	0.707	0.73	0	5.56	0.836	7.702	0.834	0.888	0.391	1	0.715	0.994	0.587	19.569	0.954	1	0.57691426
MLH1	Q346H	Pathogenic	reviewed by expert panel	P40692	1	756	34	0	4.1	161	-3.5	1.17	2.2	167	-3.2	1.24	-1.9	6	0.3	0.07	77.38665344	89.36	33.81	0.878787879	0	0	-1.151	-4.463	-3.312	0.001	0.784	1	1	0.899	1	0.997	0.85	1	0	0.843	1	1	0.81	1	3.035	0.868	1	-3.38	0.942	1	-4.87	0.813	1	0.86	0.913	0.284	0.873	1	0.575	0.847	1				6.24	0.862	28.9	0.998	0.854	0.998	0.992	1	1	0.747	0.707	0.73	0	5.23	0.725	9.291	0.951	1.048	0.713	1	0.715	1	0.888	19.001	0.928	0	0.454912556
MLH1	G22A	Benign	reviewed by expert panel	P40692	0	756	34	0	7.1	66	-0.4	0.53	7.5	92	1.8	1.45	0.4	26	2.2	0.92	77.38665344	89.36	81.23	0.047619048	2	0	-0.744	-2.339	-1.595	0	0.912	1	1	0.899	1	0.993	0.797	1	0	0.843	1	1	0.81	1	3.54	0.933	1	-2.79	0.91	1	-4.86	0.812	1	0.894	0.883	0.932	0.961	1	0.861	0.954	1	0.634	0.969	1	5.637	0.768	26.6	0.997	0.831	0.986	0.847	1	1	0.983	0.442	0.072	0	5.11	0.691	9.488	0.969	1.045	0.669	1	0.715	1	0.888	14.295	0.657	1	0.662333792
MLH1	A281V	Pathogenic	reviewed by expert panel	P40692	1	756	34	0	7.5	92	1.8	1.45	6.5	142	4.2	1.14	-1	50	2.4	-0.31	77.38665344	89.36	90.43	0.716981132	2	0	-1.671	-2.945	-1.274	0.046	0.555	1	0.736	0.409	1	0.501	0.459	1	0	0.523	1	1	0.588	1	2.435	0.708	1	-1.52	0.815	1	-2.95	0.636	1	0.744	0.748	-0.154	0.788	0	0.413	0.761	0	0.075	0.722	1	4.053	0.544	23.7	0.998	0.891	0.974	0.74	1	1	0.747	0.707	0.73	0	4.47	0.536	5.866	0.691	0.892	0.403	1	0.715	0.998	0.697	13.422	0.603	0	0.248280605
MUTYH	V493F	Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	Q9UIF7	1	546	16	0	6.5	142	4.2	1.14	3.9	203	2.8	1.12	-2.6	61	-1.4	-0.02	78.89992674	92.835	95.04	0.267605634	2	-1	-2.432	-3.294	-0.862	0.001	0.784	1	0.996	0.67	1	0.946	0.666	1	0.042	0.239	0	0.996	0.81	1	2.485	0.726	1	-3.26	0.936	1	-3.46	0.677	1	0.657	0.957	0.955	0.965	1	0.887	0.963	1				6.523	0.898	31	0.996	0.764	0.936	0.583	1	1	0.747	0.707	0.73	0	5.5	0.813	3.531	0.531	0.935	0.49	1	0.715	0.968	0.456	15.257	0.732	0	0.259513984
MUTYH	L11R	Likely benign	criteria provided, single submitter	Q9UIF7	0	546	16	0	9.1	168	4.5	1.34	5.2	225	-4.5	0.79	-3.9	57	-9	-0.55	78.89992674	92.835	28.48	1	0	-2	-1.76	-3.775	-2.015																																																													1	0.503415864
TSC2	R454S	Likely benign	criteria provided, multiple submitters, no conflicts	P49815	0	1807	38	0	5.2	225	-4.5	0.79	7.4	99	-0.8	0.79	2.2	-126	3.7	0	68.37425014	83.72	86.88	0.415322581	0	-1	-1.582	-3.067	-1.485	0.006	0.682	1	0.994	0.764	1	0.98	0.875	1	0	0.843	1	1	0.81	1	1.81	0.478	0	-0.22	0.796	0	-3.65	0.699	1	0.944	0.95	-0.374	0.728	0	0.403	0.754	0	0.152	0.834	1	4.478	0.599	24.2	0.996	0.742	0.903	0.512	1	0.897	0.26	0.707	0.73	0	4.27	0.498	5.22	0.649	0.949	0.536	1	0.715	0.086	0.183	11.325	0.485	1	0.567187398
TSC2	E456K	Benign/Likely benign	criteria provided, multiple submitters, no conflicts	P49815	0	1807	38	0	6.3	155	-3.5	1.53	5.8	171	-3.9	1.07	-0.5	16	-0.4	-0.46	68.37425014	83.72	90.19	0.067010309	0	1	-1.404	-2.689	-1.285	0.003	0.912	1	1	0.899	1	0.974	0.85	1	0	0.559	1	1	0.81	1	2.455	0.715	1	-0.36	0.799	0	-2.39	0.615	0	0.744	0.807	-0.002	0.822	0	0.49	0.806	0	0.221	0.878	1	5.723	0.781	26.9	0.999	0.973	0.914	0.533	1	1	0.473	0.707	0.73	0	5.24	0.728	7.19	0.771	0.949	0.536	1	0.715	0.061	0.171	18.812	0.92	1	0.569142595
TSC2	I1648T	Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	P49815	1	1807	38	0	5.5	169	3.8	1	6	122	-0.7	0.82	0.5	-47	-4.5	-0.18	68.37425014	83.72	95.99	0	1	-1	-1.666	-3.114	-1.448	0.001	0.784	1	0.992	0.764	1	0.975	0.764	1	0	0.629	1	1	0.548	1	3.36	0.914	1	-4.62	0.979	1	-4.22	0.758	1	0.912	0.902	1.099	0.996	1	0.964	0.988	1	0.872	0.99	1	4.982	0.67	25.1	0.997	0.802	0.983	0.81	1	1	0.747	0.672	0.522	0	5.09	0.685	7.924	0.869	0.954	0.563	1	0.715	0.208	0.219	14.87	0.7	0	0.47696011
TSC2	S1095N	Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	P49815	1	1807	38	0	7.4	99	-0.8	0.79	4.6	135	-3.5	0.73	-2.8	36	-2.7	-0.06	68.37425014	83.72	28.48	0.807692308	0	1	-1.634	-3.084	-1.45	0.094	0.324	0	0.002	0.353	0	0.009	0.275	0	0	0.513	1	0.994	0.455	1	0.41	0.124	0	-2.44	0.892	1	-0.74	0.208	0	0.428	0.507	-0.248	0.764	0	0.357	0.72	0				1.148	0.205	11.47	0.983	0.399	0.97	0.717	1	1	0.747	0.732	0.924	0	4.71	0.589	6.468	0.733	1.048	0.713	1	0.715	0.517	0.274	16.215	0.819	0	0.048395232
TSC2	V1646M	Pathogenic/Likely pathogenic	criteria provided, multiple submitters, no conflicts	P49815	1	1807	38	0	6.5	142	4.2	1.14	2.8	171	1.9	1.2	-3.7	29	-2.3	0.06	68.37425014	83.72	94.31	0	1	1	-1.465	-3.712	-2.247	0.001	0.912	1	0.998	0.899	1	0.999	0.916	1	0	0.843	1	1	0.81	1	3.825	0.957	1	-4.54	0.977	1	-2.72	0.579	1	0.787	0.793	1.087	0.991	1	0.971	0.991	1	0.94	0.996	1	5.353	0.725	25.9	0.998	0.912	0.983	0.809	1	1	0.747	0.672	0.522	0	5.09	0.685	8.054	0.892	0.943	0.531	1	0.715	0.151	0.205	18.492	0.908	0	0.462677671
TSC2	F239C	Benign/Likely benign	criteria provided, multiple submitters, no conflicts	P49815	0	1807	38	0	3.9	203	2.8	1.12	1.8	106	2.5	0.77	-2.1	-97	-0.3	-0.35	68.37425014	83.72	92.62	0.005076142	2	-2	-1.524	-4.544	-3.02	0	0.912	1	1	0.899	1	0.999	0.916	1	0	0.843	1	1	0.81	1	1.99	0.54	1	-1.33	0.799	0	-5.92	0.932	1	0.893	0.908	-0.013	0.82	0	0.561	0.84	1	0.493	0.95	1	5.598	0.762	26.5	0.993	0.595	0.986	0.846	1	1	0.747	0.672	0.522	0	5.05	0.674	7.908	0.867	0.964	0.58	1	0.715	0.736	0.318	14.806	0.694	1	0.574166503
TSC2	L309H	Likely benign	criteria provided, multiple submitters, no conflicts	P49815	0	1807	38	0	9.1	168	4.5	1.34	2.2	167	-3.2	1.24	-6.9	-1	-7.7	-0.1	68.37425014	83.72	84.67	0.115853659	0	-3	-1.347	-4.587	-3.24	0	0.912	1	1	0.899	1	0.998	0.971	1	0	0.843	1	1	0.81	1	2.08	0.576	1	-1.47	0.811	0	-4.29	0.809	1	0.952	0.956	0.265	0.87	1	0.626	0.869	1	0.668	0.972	1	5.165	0.697	25.5	0.985	0.42	0.983	0.811	1	1	0.747	0.732	0.924	0	5.12	0.693	7.628	0.822	1.061	0.807	1	0.715	0.977	0.48	15.209	0.728	1	0.685029803
POLE	E1956V	Likely pathogenic	criteria provided, single submitter	Q07864	1	2286	21	0	6.3	155	-3.5	1.53	6.5	142	4.2	1.14	0.2	-13	7.7	-0.39	79.7008399	85.97	29.84	0.891752577	0	-2	-1.784	-3.571	-1.787	0.038	0.427	1	0.22	0.448	0	0.058	0.379	0	0.74	0.098	0	0.977	0.393	1	1.955	0.53	1	0.75	0.502	0	-1.58	0.381	0	0.421	0.484	-1.053	0.136	0	0.111	0.398	0	0.031	0.536	1	1.853	0.284	15.3	0.963	0.288	0.61	0.311	1	1	0.747	0.707	0.73	0	2.89	0.326	1.013	0.293	0.029	0.149	0.124	0.23	0	0.016	8.834	0.341	0	0.173819349
RAD51D	D90G	Benign/Likely benign	criteria provided, multiple submitters, no conflicts	O75771	0	328	21	0	5.2	125	-3.5	0.98	7.1	66	-0.4	0.53	1.9	-59	3.1	-0.45	87.9335061	93.095	95.74	0.128834356	2	-1	-1.073	-2.187	-1.114				0.001	0.067	0	0.002	0.063	0				1	0.09	0				0.92	0.445	0				0.027	0.009	-0.959	0.394	0	0.222	0.586	0	0.009	0.235	0	-0.625	0.049	0.108	0.922	0.21	0.025	0.069	0	1	0.747	0.476	0.093	0	-3.38	0.045	-0.771	0.048	0.829	0.338	0	0.063	0.005	0.09	4.543	0.114	1	0.673567171
POLH	V243A	Likely benign	criteria provided, single submitter	Q9Y253	0	713	18	0	6.5	142	4.2	1.14	7.5	92	1.8	1.45	1	-50	-2.4	0.31	76.81900421	96.61	98.46	0.028169014	2	0	-1.117	-2.889	-1.772	0.585	0.114	0	0	0.067	0	0.003	0.112	0	0.237	0.158	0	1	0.09	0	0.025	0.08	0	1.31	0.354	0	-0.86	0.234	0	0.02	0.013	-0.99	0.326	0	0.02	0.086	0	0.004	0.111	0	-0.515	0.055	0.202	0.894	0.182	0.01	0.038	0	0.477	0.207	0.707	0.73	0	-4.23	0.035	-0.211	0.093	-0.889	0.027	0.003	0.159	0.743	0.32	9.313	0.369	1	0.578977533
